🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amber M. Yates

Agios Pharmaceuticals (United States)

ORCID: 0000-0001-9273-0470

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial”.

Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial

JMIR Research Protocols(2021)10.2196/27650

N/A

0.599DataRank · unranked

15 citations

Heather Strong, Cara Nwankwo, Yolanda Johnson, James Peugh, Constance A. Mara +27 more

Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia

Blood Advances(2021)10.1182/bloodadvances.2020003197

N/A

0.416DataRank · unranked

15 citations

Vijaya M. Joshi, Judith D. Goldberg, Amber M. Yates, Victoria Okhomina, Rhiannon R. Penkert +4 more

Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease

Blood Red Cells & Iron(2025)10.1016/j.brci.2025.100014

N/A

0.256DataRank · unranked

4 citations

Nancy Asomaning, Ingrid Frey, Ruth Pierre Charles, Dianna Lovins, Julia Xu +13 more